Amélie Bonnefond

17.1k total citations · 1 hit paper
118 papers, 2.7k citations indexed

About

Amélie Bonnefond is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Amélie Bonnefond has authored 118 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Genetics, 53 papers in Molecular Biology and 52 papers in Surgery. Recurrent topics in Amélie Bonnefond's work include Pancreatic function and diabetes (45 papers), Diabetes and associated disorders (23 papers) and Genetic Associations and Epidemiology (20 papers). Amélie Bonnefond is often cited by papers focused on Pancreatic function and diabetes (45 papers), Diabetes and associated disorders (23 papers) and Genetic Associations and Epidemiology (20 papers). Amélie Bonnefond collaborates with scholars based in France, United Kingdom and Canada. Amélie Bonnefond's co-authors include Philippe Froguel, Martine Vaxillaire, Michel Marre, Loïc Yengo, Emmanuelle Durand, Olivier Sand, Stéphane Lobbens, Julien Philippe, Aurélie Dechaume and Beverley Balkau and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Genetics.

In The Last Decade

Amélie Bonnefond

113 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monogenic diabetes

2023 71 citations Amélie Bonnefond, Alessandro Doria et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amélie Bonnefond France	32	1.1k	1.1k	1.1k	548	484	118	2.7k
Leen M. ‘t Hart Netherlands	30	1.5k 1.4×	663 0.6×	818 0.8×	775 1.4×	424 0.9×	98	3.0k
Jacques Philippé Switzerland	33	1.2k 1.1×	1.0k 1.0×	1.8k 1.7×	1.3k 2.4×	426 0.9×	134	3.3k
Jörg Hager France	31	824 0.7×	722 0.7×	394 0.4×	337 0.6×	750 1.5×	74	2.6k
Kentaro Yamada Japan	26	696 0.6×	535 0.5×	525 0.5×	697 1.3×	632 1.3×	83	2.3k
Enikö Kállay Austria	35	1.1k 1.0×	747 0.7×	314 0.3×	422 0.8×	454 0.9×	83	3.4k
Cécile Lecœur France	23	679 0.6×	655 0.6×	496 0.5×	336 0.6×	742 1.5×	41	2.2k
Marianne Böni‐Schnetzler Switzerland	38	1.6k 1.4×	1.1k 1.0×	1.5k 1.3×	1.4k 2.6×	816 1.7×	66	4.3k
Maı̀re E. Doyle United States	24	1.1k 1.0×	384 0.4×	1.6k 1.5×	1.7k 3.2×	466 1.0×	42	3.1k
Lisa Juntti‐Berggren Sweden	27	1.1k 1.0×	509 0.5×	1.3k 1.3×	740 1.4×	387 0.8×	72	2.6k
J. Jason Collier United States	25	679 0.6×	440 0.4×	602 0.6×	333 0.6×	485 1.0×	70	1.8k

Countries citing papers authored by Amélie Bonnefond

Since Specialization

Citations

This map shows the geographic impact of Amélie Bonnefond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Bonnefond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Bonnefond more than expected).

Fields of papers citing papers by Amélie Bonnefond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Bonnefond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Bonnefond. The network helps show where Amélie Bonnefond may publish in the future.

Co-authorship network of co-authors of Amélie Bonnefond

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Bonnefond. A scholar is included among the top collaborators of Amélie Bonnefond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Bonnefond. Amélie Bonnefond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marucci, Antonella, Mehdi Derhourhi, Claudia Menzaghi, et al.. (2025). The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis. Diabetologia. 68(10). 2240–2246. 1 indexed citations

Burrows, Kimberley, Anni Heiskala, Jonathan P. Bradfield, et al.. (2024). A framework for conducting GWAS using repeated measures data with an application to childhood BMI. Nature Communications. 15(1). 10067–10067.

Morán, Ignasi, Amélie Bonnefond, Amna Khamis, et al.. (2024). Multiple genetic variants at the SLC30A8 locus affect local super‐enhancer activity and influence pancreatic β‐cell survival and function. The FASEB Journal. 38(8). e23610–e23610. 2 indexed citations

Saha, Orthis, Karine Guyot, Yun Shen, et al.. (2024). The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons. Molecular Psychiatry. 29(9). 2634–2646. 12 indexed citations

Guerrier, Thomas, Mehdi Derhourhi, Amélie Bonnefond, et al.. (2024). Characteristics and impact of infiltration of B-cells from systemic sclerosis patients in a 3D healthy skin model. Frontiers in Immunology. 15. 1373464–1373464. 3 indexed citations

Kouidrat, Youssef, Martine Vaxillaire, Aurélie Dechaume, et al.. (2023). Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: Lessons for precision medicine. Diabetes & Metabolism. 50(1). 101507–101507. 3 indexed citations

Delemer, Brigitte, Christine Poitou, Martine Vaxillaire, et al.. (2023). Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use. Genetics in Medicine. 25(7). 100857–100857. 10 indexed citations

Aboulouard, Soulaimane, Estelle Laurent, Étienne Coyaud, et al.. (2023). Astrocytes express aberrant immunoglobulins as putative gatekeeper of astrocytes to neuronal progenitor conversion. Cell Death and Disease. 14(4). 8 indexed citations

Saha, Orthis, Amélie Bonnefond, Philippe Amouyel, et al.. (2023). Amyloid-Beta Peptides Trigger Premature Functional and Gene Expression Alterations in Human-Induced Neurons. Biomedicines. 11(9). 2564–2564. 3 indexed citations

10.

Yao, Xi, Frédérik Oger, Mehdi Derhourhi, et al.. (2023). Knocking Down CDKN2A in 3D hiPSC-Derived Brown Adipose Progenitors Potentiates Differentiation, Oxidative Metabolism and Browning Process. Cells. 12(6). 870–870. 3 indexed citations

11.

Cardon, Tristan, Soulaimane Aboulouard, Antonella Raffo‐Romero, et al.. (2023). Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome. Cell Death and Disease. 14(8). 526–526. 4 indexed citations

12.

Boutry, Raphaël, Emmanuel Vaillant, Aurélie Dechaume, et al.. (2023). Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia. 67(2). 327–332. 4 indexed citations

13.

Saeed, Sadia, Jaida Manzoor, Mickaël Canouil, et al.. (2023). High morbidity and mortality in children with untreated congenital deficiency of leptin or its receptor. Cell Reports Medicine. 4(9). 101187–101187. 16 indexed citations

14.

Khamis, Amna, Beverley Balkau, Amélie Bonnefond, et al.. (2022). Epigenetic changes associated with hyperglycaemia exposure in the longitudinal D.E.S.I.R. cohort. Diabetes & Metabolism. 48(4). 101347–101347. 2 indexed citations

15.

Lemaître, Madleen, Claire Douillard, Philippe Froguel, Amélie Bonnefond, & A. Vambergue. (2022). Management of pregnancy in a patient with congenital hyperinsulinism treated with association of diazoxide/calcium channel blocker. Acta Diabetologica. 59(8). 1117–1120.

16.

Canouil, Mickaël, Amna Khamis, Elina Keikkala, et al.. (2021). Epigenome-Wide Association Study Reveals Methylation Loci Associated With Offspring Gestational Diabetes Mellitus Exposure and Maternal Methylome. Diabetes Care. 44(9). 1992–1999. 21 indexed citations

17.

Baron, Morgane & Amélie Bonnefond. (2021). Syndrome métabolique. médecine/sciences. 37(6-7). 585–587. 1 indexed citations

18.

Griscelli, Frank, Olivier Féraud, Ali G. Turhan, et al.. (2017). Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 13 (MODY13) with a the potassium inwardly-rectifying channel, subfamily J, member 11 (KCNJ11) mutation. Stem Cell Research. 23. 178–181. 9 indexed citations

19.

Morandi, Anita, Amélie Bonnefond, Stéphane Lobbens, et al.. (2015). A girl with incomplete Prader–Willi syndrome and negative MS‐PCR, found to have mosaic maternal UPD‐15 at SNP array. American Journal of Medical Genetics Part A. 167(11). 2720–2726. 21 indexed citations

20.

Walley, Andrew J., Peter Jacobson, Mario Falchi, et al.. (2011). Differential coexpression analysis of obesity-associated networks in human subcutaneous adipose tissue. International Journal of Obesity. 36(1). 137–147. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact